These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 215476)

  • 1. Occupancy of aldosterone binding sites in rat kidney cytosol.
    Warnock DG; Edelman IS
    Mol Cell Endocrinol; 1978 Nov; 12(2):221-33. PubMed ID: 215476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates.
    Luzzani F; Glässer A
    Biochem Pharmacol; 1984 Jul; 33(14):2277-81. PubMed ID: 6235813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors.
    Funder JW; Feldman D; Highland E; Edelman IS
    Biochem Pharmacol; 1974 May; 23(10):1493-501. PubMed ID: 4367952
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
    Wambach G; Casals-Stenzel J
    Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aldosterone on incorporation of amino acids into renal medullary proteins.
    Law PY; Edelman IS
    J Membr Biol; 1978 Jun; 41(1):15-40. PubMed ID: 671518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid (type I) receptors in the olfactory mucosa of the mammal: studies with [3H]aldosterone and the anti-mineralocorticoid spironolactone.
    Kern RC; Foster JD; Pitovski DZ
    Chem Senses; 1997 Apr; 22(2):141-8. PubMed ID: 9146904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor.
    Rafestin-Oblin ME; Lombes M; Couette B; Baulieu EE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):815-21. PubMed ID: 1314085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical differences in the receptor binding of two new antimineralocorticoids.
    Agarwal MK; Kalimi M
    Biochim Biophys Acta; 1988 Jan; 964(1):105-12. PubMed ID: 2825817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties and distribution of binding sites for the mineralocorticoid receptor antagonist [3H]ZK 91587 in brain.
    Grillo C; Vallee S; McEwen BS; De Nicola AF
    J Steroid Biochem; 1990 Jan; 35(1):11-5. PubMed ID: 2155344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19-hydroxyandrostenedione does not modulate [3H]aldosterone binding to human mononuclear leucocytes and rat renal cytosol.
    Murase H; Yasuda K; Mercado-Asis LB; Mori A; Shimada T; Mune T; Morita H; Noritake N; Yamakita N; Miura K
    J Steroid Biochem Mol Biol; 1991 Mar; 38(3):331-7. PubMed ID: 2009224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidney.
    Agarwal MK; Kalimi M
    Biochem Biophys Res Commun; 1987 Feb; 143(1):398-402. PubMed ID: 3030321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304).
    Marver D; Stewart J; Funder JW; Feldman D; Edelman IS
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1431-5. PubMed ID: 4364539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and antimineralocorticoid activities of spirolactones in toad bladder.
    Rossier BC; Claire M; Rafestin-Oblin ME; Geering K; Gäggeler HP; Corvol P
    Am J Physiol; 1983 Jan; 244(1):C24-31. PubMed ID: 6217754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mineralocorticoid agonists and antagonists on binding of 3 H-aldosterone to adrenalectomized rat kidney plasma membranes.
    Forte LR
    Life Sci I; 1972 May; 11(10):461-73. PubMed ID: 4348285
    [No Abstract]   [Full Text] [Related]  

  • 17. Mineralocorticoid receptors in human kidney.
    Matulich DT; Spindler BJ; Schambelan M; Baxter JD
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.
    Beaumont K; Fanestil DD
    Endocrinology; 1983 Dec; 113(6):2043-51. PubMed ID: 6227474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone antagonists destabilize the mineralocorticosteroid receptor.
    Couette B; Lombes M; Baulieu EE; Rafestin-Oblin ME
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):697-702. PubMed ID: 1313229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of aldosterone receptors in rat kidney: effects of steroid treatment and potassium diet.
    Rafestin-Oblin ME; Claire M; Lombes M; Michaud A; Corvol P
    J Steroid Biochem; 1984 Oct; 21(4):465-70. PubMed ID: 6238210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.